William Querbes

9.3k total citations · 3 hit papers
37 papers, 5.1k citations indexed

About

William Querbes is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, William Querbes has authored 37 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in William Querbes's work include RNA Interference and Gene Delivery (15 papers), Advanced biosensing and bioanalysis techniques (10 papers) and Porphyrin Metabolism and Disorders (7 papers). William Querbes is often cited by papers focused on RNA Interference and Gene Delivery (15 papers), Advanced biosensing and bioanalysis techniques (10 papers) and Porphyrin Metabolism and Disorders (7 papers). William Querbes collaborates with scholars based in United States, Canada and Russia. William Querbes's co-authors include Kevin Fitzgerald, Walter J. Atwood, Anna Borodovsky, Victor Koteliansky, Akin Akinc, Kevin T. Love, Róbert Langer, Daniel G. Anderson, Martin A. Maier and Muthiah Manoharan and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

William Querbes

35 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape

2013 1.2k citations Jérôme Gilleron, William Querbes et al. Nature Biotechnology profile →
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery

2012 1.0k citations Hyukjin Lee, Abigail K. R. Lytton‐Jean et al. Nature Nanotechnology profile →
Lipid-like materials for low-dose, in vivo gene silencing

2010 792 citations Kevin T. Love, Kerry P. Mahon et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William Querbes United States	25	3.8k	661	644	585	517	37	5.1k
Martina Anton Germany	33	2.5k 0.7×	600 0.9×	790 1.2×	351 0.6×	583 1.1×	88	4.3k
Youli Zu United States	37	3.1k 0.8×	1.3k 1.9×	1.2k 1.9×	387 0.7×	266 0.5×	141	5.2k
Sarah Shigdar Australia	33	2.4k 0.6×	799 1.2×	828 1.3×	449 0.8×	483 0.9×	68	3.6k
Pirjo Laakkonen Finland	37	3.2k 0.8×	1.4k 2.2×	934 1.5×	419 0.7×	805 1.6×	86	5.8k
Gregg Fields United States	30	3.7k 1.0×	1.0k 1.6×	977 1.5×	983 1.7×	1.8k 3.4×	92	6.9k
Eric Wickstrom United States	37	3.3k 0.9×	661 1.0×	609 0.9×	332 0.6×	163 0.3×	155	4.9k
James E. Dahlman United States	40	5.0k 1.3×	486 0.7×	1.5k 2.4×	694 1.2×	1.4k 2.7×	76	7.3k
Sam Chen Canada	23	3.9k 1.0×	187 0.3×	715 1.1×	421 0.7×	627 1.2×	33	4.7k
Zicai Liang China	45	3.8k 1.0×	199 0.3×	1.1k 1.7×	1.2k 2.0×	948 1.8×	125	5.7k
Steven M. Ansell United States	24	3.7k 1.0×	432 0.7×	559 0.9×	387 0.7×	988 1.9×	47	4.9k

Countries citing papers authored by William Querbes

Since Specialization

Citations

This map shows the geographic impact of William Querbes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Querbes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Querbes more than expected).

Fields of papers citing papers by William Querbes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Querbes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Querbes. The network helps show where William Querbes may publish in the future.

Co-authorship network of co-authors of William Querbes

This figure shows the co-authorship network connecting the top 25 collaborators of William Querbes. A scholar is included among the top collaborators of William Querbes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Querbes. William Querbes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cotta‐Ramusino, Cecilia, James B. Rottman, Donghui Li, et al.. (2025). Targeted lnp delivery of an RNA gene writer In Vivo enables generation of functional CAR-T cells. Blood. 146(Supplement 1). 6097–6097.

Simon, Amy, Farrah Pompilus, William Querbes, et al.. (2018). Patient Perspective on Acute Intermittent Porphyria with Frequent Attacks: A Disease with Intermittent and Chronic Manifestations. Patient. 11(5). 527–537. 51 indexed citations

Xu, Yuxin, Haojie Yu, William Querbes, et al.. (2017). Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol. Atherosclerosis. 268. 196–206. 87 indexed citations

Gilleron, Jérôme, Anja Zeigerer, William Querbes, et al.. (2015). Identification of siRNA delivery enhancers by a chemical library screen. Nucleic Acids Research. 43(16). 7984–8001. 59 indexed citations

Rajeev, Kallanthottathil G., Jayaprakash K. Nair, Muthusamy Jayaraman, et al.. (2015). Hepatocyte‐Specific Delivery of siRNAs Conjugated to Novel Non‐nucleosidic Trivalent N‐Acetylgalactosamine Elicits Robust Gene Silencing in Vivo. ChemBioChem. 16(6). 903–908. 148 indexed citations

Chan, Amy, Abigail Liebow, Makiko Yasuda, et al.. (2015). Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA Quantification. Molecular Therapy — Nucleic Acids. 4. e263–e263. 108 indexed citations

Li, Xingsheng, John Knight, Sonia Fargue, et al.. (2015). Metabolism of 13C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenase. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862(2). 233–239. 29 indexed citations

Querbes, William, Scott Barros, Renta Hutabarat, et al.. (2013). Abstract 15574: A Subcutaneous Platform for RNAi Therapeutics Targeting ANGPTL3. Circulation. 128. 1 indexed citations

Gilleron, Jérôme, William Querbes, Anja Zeigerer, et al.. (2013). Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape. Nature Biotechnology. 31(7). 638–646. 1232 indexed citations breakdown →

10.

Sahay, Gaurav, William Querbes, Christopher A. Alabi, et al.. (2013). Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling. Nature Biotechnology. 31(7). 653–658. 24 indexed citations

11.

Heller, Daniel A., Y. Levi, Jeisa M. Pelet, et al.. (2012). Modular ‘Click‐in‐Emulsion’ Bone‐Targeted Nanogels. Advanced Materials. 25(10). 1449–1454. 67 indexed citations

12.

Burgess, Alison, Yuexi Huang, William Querbes, Dinah W.Y. Sah, & Kullervo Hynynen. (2012). Focused ultrasound for targeted delivery of siRNA and efficient knockdown of Htt expression. Journal of Controlled Release. 163(2). 125–129. 96 indexed citations

13.

Lee, Hyukjin, Abigail K. R. Lytton‐Jean, Yi Chen, et al.. (2012). Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nature Nanotechnology. 7(6). 389–393. 1005 indexed citations breakdown →

14.

Whitehead, Kathryn A., Gaurav Sahay, George Z. Li, et al.. (2011). Synergistic Silencing: Combinations of Lipid-like Materials for Efficacious siRNA Delivery. Molecular Therapy. 19(9). 1688–1694. 54 indexed citations

15.

Love, Kevin T., Kerry P. Mahon, Christopher G. Levins, et al.. (2010). Lipid-like materials for low-dose, in vivo gene silencing. Proceedings of the National Academy of Sciences. 107(5). 1864–1869. 792 indexed citations breakdown →

16.

Chen, Qingmin, David Butler, William Querbes, et al.. (2010). Lipophilic siRNAs mediate efficient gene silencing in oligodendrocytes with direct CNS delivery. Journal of Controlled Release. 144(2). 227–232. 49 indexed citations

17.

Querbes, William, Pei Ge, Wenjun Zhang, et al.. (2008). Direct CNS Delivery of siRNA Mediates Robust Silencing in Oligodendrocytes. Oligonucleotides. 19(1). 23–30. 30 indexed citations

18.

Eash, Sylvia, et al.. (2006). The human polyomaviruses. Cellular and Molecular Life Sciences. 63(7-8). 865–876. 73 indexed citations

19.

Elphick, Gwendolyn F., William Querbes, Gretchen V. Gee, et al.. (2004). The Human Polyomavirus, JCV, Uses Serotonin Receptors to Infect Cells. Science. 306(5700). 1380–1383. 331 indexed citations

20.

Baum, Sarah E., et al.. (2003). Early Events in the Life Cycle of JC Virus as Potential Therapeutic Targets for the Treatment of Progressive Multifocal Leukoencephalopathy. Journal of NeuroVirology. 9(s1). 32–37. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact